BR9607433A - Composição farmacêutica para administração parental - Google Patents

Composição farmacêutica para administração parental

Info

Publication number
BR9607433A
BR9607433A BR9607433A BR9607433A BR9607433A BR 9607433 A BR9607433 A BR 9607433A BR 9607433 A BR9607433 A BR 9607433A BR 9607433 A BR9607433 A BR 9607433A BR 9607433 A BR9607433 A BR 9607433A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
parental administration
parental
administration
pharmaceutical
Prior art date
Application number
BR9607433A
Other languages
English (en)
Inventor
Maria Teresa Rossato
Andrea Lodi
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of BR9607433A publication Critical patent/BR9607433A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BR9607433A 1995-02-11 1996-02-08 Composição farmacêutica para administração parental BR9607433A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition
PCT/EP1996/000515 WO1996024376A1 (en) 1995-02-11 1996-02-08 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid

Publications (1)

Publication Number Publication Date
BR9607433A true BR9607433A (pt) 1998-05-26

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607433A BR9607433A (pt) 1995-02-11 1996-02-08 Composição farmacêutica para administração parental

Country Status (18)

Country Link
US (2) US5886018A (pt)
EP (1) EP0809514A1 (pt)
JP (1) JPH10513464A (pt)
KR (1) KR19980702109A (pt)
AU (1) AU707220B2 (pt)
BR (1) BR9607433A (pt)
CA (1) CA2212041A1 (pt)
CZ (1) CZ252897A3 (pt)
EA (1) EA000211B1 (pt)
FI (1) FI973280A7 (pt)
GB (1) GB9502695D0 (pt)
HU (1) HUP9702448A2 (pt)
IL (1) IL117098A0 (pt)
NO (1) NO973656L (pt)
NZ (1) NZ300937A (pt)
PL (1) PL321734A1 (pt)
WO (1) WO1996024376A1 (pt)
ZA (1) ZA961051B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
CN1922149A (zh) 2003-12-29 2007-02-28 塞普拉科公司 吡咯和吡唑daao抑制剂
CN101123957B (zh) 2005-02-01 2010-12-08 特罗伊卡药品有限公司 双氯芬酸及其药学上可接受盐的注射剂
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN110996948A (zh) 2017-06-12 2020-04-10 格莱泰施有限责任公司 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
EP0539503B1 (en) * 1990-07-16 1996-04-03 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
WO1996024376A1 (en) 1996-08-15
FI973280L (fi) 1997-08-08
CA2212041A1 (en) 1996-08-15
AU4622896A (en) 1996-08-27
HUP9702448A2 (hu) 1999-10-28
FI973280A0 (fi) 1997-08-08
EP0809514A1 (en) 1997-12-03
US5886018A (en) 1999-03-23
US6020359A (en) 2000-02-01
NZ300937A (en) 1999-02-25
ZA961051B (en) 1996-09-11
AU707220B2 (en) 1999-07-08
NO973656D0 (no) 1997-08-08
KR19980702109A (ko) 1998-07-15
EA000211B1 (ru) 1998-12-24
GB9502695D0 (en) 1995-03-29
MX9706044A (es) 1998-06-28
NO973656L (no) 1997-10-08
IL117098A0 (en) 1996-06-18
PL321734A1 (en) 1997-12-22
CZ252897A3 (cs) 1998-03-18
FI973280A7 (fi) 1997-08-08
JPH10513464A (ja) 1998-12-22
EA199700095A1 (ru) 1998-02-26

Similar Documents

Publication Publication Date Title
NO962606D0 (no) Farmasöytisk sammensetning
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
FI973518L (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
IS4706A (is) Lyfjasamsetningar
BR9610153A (pt) Formulações farmacêuticas
BR9610396A (pt) Formulação farmacêutica
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
BR9610836A (pt) Composição antibacterial para administração oral
FI954243A7 (fi) Farmaseuttiset yhdisteet
BR9507768A (pt) Composição farmacêutica
DE69614407D1 (de) Pharmazeutische zusammensetzungen
LV11727A (lv) Farmaceitiska kompozicija
FI973229A0 (fi) Uusi farmaseuttinen koostumus
ITMI941169A0 (it) Formulazioni farmaceutiche
ID18698A (id) Komposisi farmasi
FI973280A0 (fi) Farmaseuttinen koostumus
FI973230A7 (fi) Uusi farmaseuttinen formulaatio
BR9605777A (pt) Composição farmacêutica
ITMI962628A0 (it) Composizione farmaceutica
BR9605131A (pt) Composição farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
FI964663A0 (fi) Farmaceutisk analgetisk komposition foer lokal administrering
KR960016881A (ko) 제약 조성물
SE9402437D0 (sv) Pharmaceutical composition
SE9404195D0 (sv) New pharmaceutical formulation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A,9A E 10A ANUIDADES.